Southeast Asset Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-589
| Closed | -$398K | – | 225 |
|
|
2025
Q4 | $398K | Sell |
589
-1,214
| -67% | -$827K | 0.04% | 157 |
|
|
2025
Q3 | $1.15M | Sell |
1,803
-1,336
| -43% | -$811K | 0.13% | 95 |
|
|
2025
Q2 | $1.68M | Buy |
3,139
+2,134
| +212% | +$1.02M | 0.2% | 72 |
|
|
2025
Q1 | $422K | Buy |
+1,005
| New | +$436K | 0.05% | 132 |
|
|
2024
Q2 | – | Sell |
-1,600
| Closed | -$864K | – | 168 |
|
|
2024
Q1 | $864K | Sell |
1,600
-2,220
| -58% | -$1.21M | 0.1% | 94 |
|
|
2023
Q4 | $2.12M | Buy |
3,820
+85
| +2% | +$39.9K | 0.28% | 53 |
|
|
2023
Q3 | $1.63M | Sell |
3,735
-28
| -0.7% | -$14K | 0.23% | 58 |
|
|
2023
Q2 | $1.89M | Sell |
3,763
-12
| -0.3% | -$5.75K | 0.27% | 51 |
|
|
2023
Q1 | $1.89M | Sell |
3,775
-879
| -19% | -$421K | 0.28% | 51 |
|
|
2022
Q4 | $1.9M | Buy |
4,654
+305
| +7% | +$118K | 0.3% | 49 |
|
|
2022
Q3 | $1.42M | Sell |
4,349
-497
| -10% | -$183K | 0.24% | 57 |
|
|
2022
Q2 | $1.7M | Buy |
+4,846
| New | +$1.98M | 0.27% | 50 |
|
|
2018
Q2 | – | Sell |
-2,282
| Closed | -$437K | – | 109 |
|
|
2018
Q1 | $437K | Buy |
2,282
+665
| +41% | +$123K | 0.13% | 74 |
|
|
2017
Q4 | $253K | Hold |
1,617
| – | – | 0.08% | 102 |
|
|
2017
Q3 | $251K | Hold |
1,617
| – | – | 0.08% | 96 |
|
|
2017
Q2 | $261K | Sell |
1,617
-2,165
| -57% | -$352K | 0.08% | 92 |
|
|
2017
Q1 | $585K | Sell |
3,782
-5,838
| -61% | -$805K | 0.18% | 63 |
|
|
2016
Q4 | $1.13M | Sell |
9,620
-355
| -4% | -$40.5K | 0.36% | 38 |
|
|
2016
Q3 | $1.12M | Sell |
9,975
-3,695
| -27% | -$389K | 0.38% | 33 |
|
|
2016
Q2 | $1.27M | Sell |
13,670
-3,380
| -20% | -$290K | 0.42% | 32 |
|
|
2016
Q1 | $1.33M | Sell |
17,050
-5,590
| -25% | -$403K | 0.43% | 26 |
|
|
2015
Q4 | $1.65M | Buy |
22,640
+940
| +4% | +$67.1K | 0.56% | 21 |
|
|
2015
Q3 | $1.61M | Sell |
21,700
-110
| -0.5% | -$7.88K | 0.61% | 20 |
|
|
2015
Q2 | $1.4M | Buy |
21,810
+7,690
| +54% | +$532K | 0.5% | 25 |
|
|
2015
Q1 | $1.09M | Hold |
14,120
| – | – | 0.38% | 35 |
|
|
2014
Q4 | $1.05M | Hold |
14,120
| – | – | 0.38% | 38 |
|
|
2014
Q3 | $832K | Buy |
+14,120
| New | +$893K | 0.32% | 44 |
|
Other funds holding IDXX
VCM
VPM
Southeast Asset Advisors's IDXX Position: Q1 2026 in Review
Southeast Asset Advisors sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 589 shares — an estimated $398K sold.
Southeast Asset Advisors first reported a position in IDXX in Q3 2014 and held it in 27 quarters. The position peaked at $2.12M in Q4 2023. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Southeast Asset Advisors reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
- Southeast Asset Advisors sold 589 Idexx Laboratories shares in Q1 2026, an estimated $398K.
- Southeast Asset Advisors first reported a position in Idexx Laboratories in Q3 2014 and held it in 27 quarters.
- Southeast Asset Advisors's Idexx Laboratories position peaked at $2.12M in Q4 2023.
- 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Southeast Asset Advisors's 13F filing for Q1 2026, filed 13 May 2026.